Who will get cancer treatment-induced cardiotoxicity?

LAS VEGAS – The search is on for predictors of which cancer patients will experience treatment-induced cardiotoxicity, and an initial report from the PREDICT study has identified several. One...

Field of Interest: Oncology
Type: News Item

Colorectal cancer on the increase in young adults

Colorectal cancer rates have declined in both men and women since 1975, particularly in those over age 75 years, but there has also been a significant increase in the incidence among those aged 20-34...

Field of Interest: Gastroentero...
Type: News Item

Colorectal cancer on the increase in young adults

Colorectal cancer rates have declined in both men and women since 1975, particularly in those over age 75 years, but there has also been a significant increase in the incidence among those aged 20-34...

Field of Interest: Oncology
Type: News Item

‘Chemo brain’ may have targetable causes

BOSTON – The risk for cognitive decline following cancer treatment varies by both cancer and therapy types, and can range from subtle changes to severe deficits, according to a researcher. Patients...

Field of Interest: Oncology
Type: News Item

ROR score aids prognosis after 5 years on tamoxifen

The risk of recurrence (ROR) score provides clinically meaningful prognostic information after postmenopausal women with early-stage breast cancer complete 5 years of tamoxifen therapy, according to...

Field of Interest: Oncology
Type: News Item

ROR score aids prognosis after 5 years on tamoxifen

The risk of recurrence (ROR) score provides clinically meaningful prognostic information after postmenopausal women with early-stage breast cancer complete 5 years of tamoxifen therapy, according to...

Field of Interest: Pulmonology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness